ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 24 Issue : 2
Current Issue Archive Popular Article Ahead of Print

 
Aspirin in cardiovascular prevention: Does the approach differ by gender? [Anatol J Cardiol]
Anatol J Cardiol. 2007; 7(Suppl 2): 2-4

Aspirin in cardiovascular prevention: Does the approach differ by gender?

Ahmet Temizhan1
Department of Cardiology, Türkiye Yüksek İhtisas Hospital, Ankara

Although aspirin is effective in the treatment of acute coronary syndrome and in the secondary prevention of cardiovascular disease among both men and women, its use in primary prevention remains controversial. The gender-specific meta-analysis demonstrates that the specific types of benefit of aspirin therapy differ between women and men in primary prevention. For primary prevention of cardiovascular disease in women, aspirin therapy significantly reduced the risk of the composite of cardiovascular events primarily by its effect on reducing the risk of stroke In contrast, in men; aspirin therapy significantly reduced the risk of the composite of cardiovascular eventspredominantly by reducing the risk of myocardial infarction. The reasons for any sex-based differences in the efficacy of aspirin for primary prevention are unclear and require further exploration.

Keywords: Aspirin, cardiovascular disease, prevention, sex


Kardiyovasküler korumada aspirin: Cinsiyete göre farkl bir yaklaşım var mı?

Ahmet Temizhan1
Department of Cardiology, Türkiye Yüksek İhtisas Hospital, Ankara

Anahtar Kelimeler: Aspirin, kardiyovasküler hastalık, koruma, cinsiyet


Ahmet Temizhan. Aspirin in cardiovascular prevention: Does the approach differ by gender?. Anatol J Cardiol. 2007; 7(Suppl 2): 2-4


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2019 Turkish Society of Cardiology